Researchers have developed a therapy for a potentially deadly type of infection common in catheters, artificial joints and other ‘in-dwelling’ medical devices. The therapy targets fungal infections, which are hard to treat in such devices because they are composed of biofilms—complex groupings of cells that attach to surfaces. Biofilms, in turn, are coated in a gooey matrix that resists drugs.